Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Krieket - Kovsies klop SUT
2005-01-31

Johan de Jager - Volksblad OFSKOON die spanne nie op volsterkte was nie, was die superligawedstryd tussen die Universteit van die Vrystaat (UV) en die Sentrale Universiteit vir Tegnologie, Vrystaat (SUT), Saterdag op Tokkiepark in Bloemfontein 'n toonbeeld van goeie klubkrieket. Die Kovsies het hul onoorwonne rekord behou toe hulle met ses paaltjies geseëvier het. Hulle het die wenteiken van 233 lopies in die 48ste boulbeurt oortref. Die voormalige kaptein Gerald Fourie (95 nun) het die aanslag gelei, terwyl die wenspan se Ryan McLaren (2/46 en 46) 'n veelsydige vertoning gelewer het. McLaren het hom op 'n driekuns bevind toe hy die laaste twee paaltjies ingeoes en toe byna 'n vyftigtal gemoker het. Die tuisspan het goed begin. Hy het egter ses paaltjies in die laaste tien boulbeurte verloor. Die Kovsies het mooi herstel nadat hulle 24/2 gehad het. Die tuisspan se Dewald Pretorius het met 2/11 ná agt boulbeurte gespog . Die wedstryd op CBCOB se veld tussen die tuisspan en SUT II is ná 'n ruk se spel aanvanklik afgelas omdat toestande as te gevaarlik bestempel is, maar is later die middag hervat en oor 25 boulbeurte aan 'n kant beslis . SUT II is vir 82 lopies uitgehaal, waarna CBCOB die wenlopies behaal het met nog vier paaltjies staande . Schoemanpark was in Mangaung met vyf paaltjies aan die wenkant teen Rocklands, terwyl Polisie sy tweede agtereenvolgende nederlaag in die tweede ronde gely het nadat die Peshawars hom naelskraap met 'n paaltjie op die UV-ovaal geklop het. Die tuisspan se Ferdi Botha (116) se honderdtal het gehelp dat die Peshawars die wedstryd met nog twee aflewerings oor kon wen nadat Polisie vroeër 221/8 aangeteken het. Die beknopte telkaarte is: SUT 232 (I. O'Neill 37, H. von Rauenstein 67, G. Liebenberg 26, G. McLaren 28; C. Deacon 2/47, R. McLaren 2/46, G. Perry 2/29, C. Ingram 2/44); UV 234/4 (R. McLaren 46, G. Fourie 95 nun, C. Linde 27, E. Weirich 27 nun; D. Pretorius 2/29). Kovsies wen met ses paaltjies. SUT II 82 (J. Labuscagne 21, A. van Deventer 16; J. Chemaly 3/11, M. Mashimbyi 2/7, J. Malao 2/19); CBCOB 84/6 (M. Mashimbyi 22, T. van der Westhuizen 21, P. Stander 21; R. Daniël 2/6, R. Wessels 2/17). CBCOB wen met vier paaltjies. Rocklands 107 (D. Makopanele 22); Schoemanpark 108/5 (J. Smith 37; N. Sefuthi 2/14). Schoemanpark wen met vyf paaltjies. Polisie 221/8 (W. Nel 86, B. Hector 62; N. de Bruin 4/49, J. Mostert 1/19, R. de Kock 2/50); Peshawars 222/9 (F. Botha 116, J. Mostert 26; W. Thies 3/30, E. van Niekerk 3/43). Peshawars wen met 'n paaltjie.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept